Compound name
Amivantamab
Compound Image
Amivantamab.png
Approval Jurisdiction
2021 FDA
Approved for clinical use
NSCLC
CAS
2171511-58-1
Action
EGFR/MET
Approved Drug List
1
Commercial Vendor
Janssen
Reference
Reference 2